CN103467569B - 一种抗菌止痒消炎消肿去疤痕的短肽及其应用 - Google Patents
一种抗菌止痒消炎消肿去疤痕的短肽及其应用 Download PDFInfo
- Publication number
- CN103467569B CN103467569B CN201310346091.XA CN201310346091A CN103467569B CN 103467569 B CN103467569 B CN 103467569B CN 201310346091 A CN201310346091 A CN 201310346091A CN 103467569 B CN103467569 B CN 103467569B
- Authority
- CN
- China
- Prior art keywords
- small peptide
- short peptide
- tyr
- present
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 168
- 208000003251 Pruritus Diseases 0.000 title claims abstract description 56
- 231100000241 scar Toxicity 0.000 title claims abstract description 35
- 206010061218 Inflammation Diseases 0.000 title claims abstract description 34
- 241000894006 Bacteria Species 0.000 title claims abstract description 18
- 230000004054 inflammatory process Effects 0.000 title abstract description 15
- 230000008961 swelling Effects 0.000 title abstract description 10
- 230000007803 itching Effects 0.000 title abstract description 9
- 230000003467 diminishing effect Effects 0.000 title abstract 4
- 239000003814 drug Substances 0.000 claims abstract description 11
- 201000009053 Neurodermatitis Diseases 0.000 claims abstract description 9
- 241000191967 Staphylococcus aureus Species 0.000 claims description 65
- 230000000844 anti-bacterial effect Effects 0.000 claims description 39
- 238000002360 preparation method Methods 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 abstract description 62
- 239000002773 nucleotide Substances 0.000 abstract description 41
- 125000003729 nucleotide group Chemical group 0.000 abstract description 41
- 201000004624 Dermatitis Diseases 0.000 abstract description 18
- 206010012442 Dermatitis contact Diseases 0.000 abstract description 7
- 208000006877 Insect Bites and Stings Diseases 0.000 abstract description 7
- 208000010247 contact dermatitis Diseases 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 3
- 108010033276 Peptide Fragments Proteins 0.000 abstract 2
- 102000007079 Peptide Fragments Human genes 0.000 abstract 2
- 208000032544 Cicatrix Diseases 0.000 abstract 1
- 239000000645 desinfectant Substances 0.000 abstract 1
- 230000000249 desinfective effect Effects 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 231100000956 nontoxicity Toxicity 0.000 abstract 1
- 230000037387 scars Effects 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 description 39
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 28
- 210000003491 skin Anatomy 0.000 description 24
- 238000000034 method Methods 0.000 description 23
- 239000007921 spray Substances 0.000 description 17
- 230000000694 effects Effects 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- 238000003786 synthesis reaction Methods 0.000 description 16
- 230000015572 biosynthetic process Effects 0.000 description 15
- 239000001888 Peptone Substances 0.000 description 14
- 108010080698 Peptones Proteins 0.000 description 14
- 239000007788 liquid Substances 0.000 description 14
- 235000015097 nutrients Nutrition 0.000 description 14
- 235000019319 peptone Nutrition 0.000 description 14
- 239000011780 sodium chloride Substances 0.000 description 14
- 239000007790 solid phase Substances 0.000 description 13
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 12
- 238000004128 high performance liquid chromatography Methods 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 238000005507 spraying Methods 0.000 description 11
- 108020004414 DNA Proteins 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 229910021642 ultra pure water Inorganic materials 0.000 description 9
- 239000012498 ultrapure water Substances 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 8
- 229920001817 Agar Polymers 0.000 description 7
- 206010003399 Arthropod bite Diseases 0.000 description 7
- 241001052560 Thallis Species 0.000 description 7
- 239000008272 agar Substances 0.000 description 7
- 230000001139 anti-pruritic effect Effects 0.000 description 7
- 239000003908 antipruritic agent Substances 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 238000005352 clarification Methods 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 7
- 239000010931 gold Substances 0.000 description 7
- 229910052737 gold Inorganic materials 0.000 description 7
- 230000000452 restraining effect Effects 0.000 description 7
- 208000017520 skin disease Diseases 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 230000001954 sterilising effect Effects 0.000 description 7
- 238000004659 sterilization and disinfection Methods 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- 206010015150 Erythema Diseases 0.000 description 6
- 230000000975 bioactive effect Effects 0.000 description 6
- 230000008034 disappearance Effects 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 230000001154 acute effect Effects 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- -1 Gla amino acid Chemical class 0.000 description 4
- JJKKWYQVHRUSDG-GUBZILKMSA-N Glu-Ala-Lys Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O JJKKWYQVHRUSDG-GUBZILKMSA-N 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- KHCSOLAHNLOXJR-BZSNNMDCSA-N Tyr-Leu-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O KHCSOLAHNLOXJR-BZSNNMDCSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 241000255925 Diptera Species 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- BAAVRTJSLCSMNM-CMOCDZPBSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-carboxybutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]pentanedioic acid Chemical compound C([C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=C(O)C=C1 BAAVRTJSLCSMNM-CMOCDZPBSA-N 0.000 description 2
- SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- UNUZEBFXGWVAOP-DZKIICNBSA-N Tyr-Glu-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O UNUZEBFXGWVAOP-DZKIICNBSA-N 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- KBKGRMNVKPSQIF-XDTLVQLUSA-N Glu-Ala-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KBKGRMNVKPSQIF-XDTLVQLUSA-N 0.000 description 1
- 241001313288 Labia Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- LABUITCFCAABSV-BPNCWPANSA-N Val-Ala-Tyr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 LABUITCFCAABSV-BPNCWPANSA-N 0.000 description 1
- BZWUSZGQOILYEU-STECZYCISA-N Val-Ile-Tyr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 BZWUSZGQOILYEU-STECZYCISA-N 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 208000002029 allergic contact dermatitis Diseases 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 208000001875 irritant dermatitis Diseases 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 208000002440 photoallergic dermatitis Diseases 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- 231100000018 phototoxicity Toxicity 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (1)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310346091.XA CN103467569B (zh) | 2013-08-10 | 2013-08-10 | 一种抗菌止痒消炎消肿去疤痕的短肽及其应用 |
CN201510289839.6A CN104840940B (zh) | 2013-08-10 | 2013-08-10 | 一种抗菌止痒消炎消肿去疤痕的短肽的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310346091.XA CN103467569B (zh) | 2013-08-10 | 2013-08-10 | 一种抗菌止痒消炎消肿去疤痕的短肽及其应用 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510289839.6A Division CN104840940B (zh) | 2013-08-10 | 2013-08-10 | 一种抗菌止痒消炎消肿去疤痕的短肽的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103467569A CN103467569A (zh) | 2013-12-25 |
CN103467569B true CN103467569B (zh) | 2015-05-20 |
Family
ID=49792633
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310346091.XA Active CN103467569B (zh) | 2013-08-10 | 2013-08-10 | 一种抗菌止痒消炎消肿去疤痕的短肽及其应用 |
CN201510289839.6A Active CN104840940B (zh) | 2013-08-10 | 2013-08-10 | 一种抗菌止痒消炎消肿去疤痕的短肽的应用 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510289839.6A Active CN104840940B (zh) | 2013-08-10 | 2013-08-10 | 一种抗菌止痒消炎消肿去疤痕的短肽的应用 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN103467569B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103554236B (zh) * | 2013-11-05 | 2015-06-17 | 李�昊 | 一种促进植物生根、发芽、生长和延长贮存期的短肽及其应用 |
CN104817622A (zh) * | 2014-01-30 | 2015-08-05 | 陈光健 | 寡肽cd04及其制备方法和应用 |
CN104817625A (zh) * | 2014-01-30 | 2015-08-05 | 陈光健 | 寡肽cd03及其制备方法和应用 |
CN110559476B (zh) * | 2019-09-26 | 2020-10-16 | 浙江海洋大学 | 一种含有肽类抗炎活性成分的液体创可贴及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101395172A (zh) * | 2006-02-10 | 2009-03-25 | 德玛根股份公司 | 新型抗微生物肽及其应用 |
CN103415532A (zh) * | 2011-01-20 | 2013-11-27 | 万德-生物技术及制药有限公司 | 抗氧化、抗炎、抗辐射、金属螯合的化合物及其用途 |
-
2013
- 2013-08-10 CN CN201310346091.XA patent/CN103467569B/zh active Active
- 2013-08-10 CN CN201510289839.6A patent/CN104840940B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101395172A (zh) * | 2006-02-10 | 2009-03-25 | 德玛根股份公司 | 新型抗微生物肽及其应用 |
CN103415532A (zh) * | 2011-01-20 | 2013-11-27 | 万德-生物技术及制药有限公司 | 抗氧化、抗炎、抗辐射、金属螯合的化合物及其用途 |
Non-Patent Citations (1)
Title |
---|
High-level expression of secreted complex glycosylated recombinant human erythropoietin in the Physcomitrella Δ-fuc-t Δ-xyl-t mutant;Andreas Weise et al;《Plant Biotechnology Journal》;20071231(第5期);389–401 * |
Also Published As
Publication number | Publication date |
---|---|
CN103467569A (zh) | 2013-12-25 |
CN104840940A (zh) | 2015-08-19 |
CN104840940B (zh) | 2018-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kosikowska et al. | Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003–2015) | |
CN103467569B (zh) | 一种抗菌止痒消炎消肿去疤痕的短肽及其应用 | |
KR101899552B1 (ko) | 전복에서 유래한 항균 펩타이드 유사체 및 이를 포함하는 항균용 약학 조성물 | |
BRPI0412125A (pt) | molécula de ácido nucleico isolada, polipeptìdeo de fusão, vetor de expressão, método de produzir um polipeptìdeo de fusão de vegf, captador de fator de crescimento de célula endotelial vascular, composição farmacêutica, método de tratar uma doença ou condição que são restabelecidas, melhoradas ou inibidas pela remoção ou inibição do fator de crescimento endotelial vascular, e, artigo de fabricação | |
KR102007762B1 (ko) | 반려동물 피모 관리용 조성물 | |
JP6066222B2 (ja) | 抗菌ペプチド及びその利用 | |
CN106279439A (zh) | 一种含有穿膜肽的寡肽‑1融合蛋白及其制备方法 | |
CN107849551A (zh) | 新型胰蛋白酶同功异型物和其用途 | |
JP6900324B2 (ja) | 抗微生物ペプチド | |
TW201706293A (zh) | 具有抗病原菌功效的抗菌胜肽及其製藥用途 | |
CN101443352A (zh) | 从Gaegurin 5合成和制备的抗菌和抗癌多肽的新型类似物 | |
CN101878226B (zh) | 精氨酸取代的新型合成肽及其应用 | |
CN107921102B (zh) | 组合疗法 | |
ES2287527T3 (es) | Peptidos lineales cationicos que tienen propiedades antifungicas. | |
ES2212357T3 (es) | Peptidos bifidogenos y su uso. | |
CN115043924B (zh) | 一种改造体抗菌肽及其应用 | |
CN114716515A (zh) | 一种多肽类似物及其制备方法和应用 | |
CN105837674A (zh) | 一种东方铃蟾多肽及其制备方法与应用 | |
US20190284252A1 (en) | Engineered fgf1 and fgf2 compositions and methods of use thereof | |
JP5791066B2 (ja) | 上皮細胞の増殖促進方法、及び上皮細胞の増殖促進剤 | |
CN102816206B (zh) | 合成肽及其应用 | |
CN114957394B (zh) | 一种促皮肤修复多肽pm-7及应用 | |
CN112625139B (zh) | 一种蛋白及其在促进皮肤成纤维细胞迁移、抗菌和创口修复中的应用 | |
CN108350030A (zh) | 皮肤可渗透肽及其使用方法 | |
KR102540598B1 (ko) | 태평양굴에서 유래한 항균 펩타이드 및 이의 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170630 Address after: 350109, A501, room 5, building 10, Haixi garden, Innovation Zone, Fuzhou hi tech Zone, Fujian Patentee after: FUJIAN LANHAOBIO TECH. Co.,Ltd. Address before: 350002, No. 607, No. 8, No. 118 West 2nd Ring Road, Taijiang District, Fujian, Fuzhou Patentee before: Li Hao |
|
TR01 | Transfer of patent right |
Effective date of registration: 20170907 Address after: 350002, 7, building 501, 523 Industrial Road, Gulou District, Fujian, Fuzhou, China Patentee after: Li Hao Address before: 350109, A501, room 5, building 10, Haixi garden, Innovation Zone, Fuzhou hi tech Zone, Fujian Patentee before: FUJIAN LANHAOBIO TECH. Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180928 Address after: 350108 A501, 10 / F, hi tech Industrial Park, hi tech Zone, Fuzhou, Fujian. Patentee after: FUJIAN LANHAO PEPTIDE BIOTECHNOLOGY DEVELOPMENT CO.,LTD. Address before: 350002 Red Road 7, 501, industrial road, Gulou District, Fuzhou, Fujian, China, 523 Patentee before: Li Hao |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240308 Address after: 350002 Red Road 7, 501, industrial road, Gulou District, Fuzhou, Fujian, China, 523 Patentee after: Li Hao Country or region after: China Address before: 350108 A501, 10 / F, hi tech Industrial Park, hi tech Zone, Fuzhou, Fujian. Patentee before: FUJIAN LANHAO PEPTIDE BIOTECHNOLOGY DEVELOPMENT CO.,LTD. Country or region before: China |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240401 Address after: 350000 on the first floor of Building 4, New Drug Creation Center, Biopark, High tech Zone, Fuzhou City, Fujian Province Patentee after: FUJIAN LANHAO PEPTIDE BIOTECHNOLOGY DEVELOPMENT CO.,LTD. Country or region after: China Address before: 350002 Red Road 7, 501, industrial road, Gulou District, Fuzhou, Fujian, China, 523 Patentee before: Li Hao Country or region before: China |